The company presented new chromatography media for large-particle biopharmaceutical manufacturing at BioProcess International 2026.
Live Poll
Do you believe new pharmaceutical manufacturing technologies will lead to better health outcomes?
September 24, 2026
Researchers Developed Protein Database Compression MethodA new algorithm enables taxonomic classification of massive protein datasets with significantly lower memory usage.
September 24, 2026
Researchers Developed SIMworks Software SuiteThe new integrated platform streamlines data processing and quality control for structured illumination microscopy.
September 24, 2026
Henlius Biotech Signed 440 Million Dollar DealShanghai-based Henlius Biotech has partnered with California firm Amberstone Biosciences to develop new cancer therapies.
September 24, 2026
Daiichi Sankyo Expanded Turbine ADC PartnershipThe pharmaceutical company is utilizing AI simulation technology to accelerate the discovery of new drug therapies.
September 24, 2026
Eli Lilly and InnoCare Pharma Signed Licensing AgreementThe pharmaceutical companies have established a new partnership to develop treatments for up to five disease targets.
September 23, 2026
Researchers Developed High-Throughput Proteomics PlatformA new nanoLC-MS system enables the rapid identification of thousands of proteins from single cells.
September 23, 2026
Allotera Therapeutics Opened New T-RRex Study CohortThe clinical trial is evaluating a gene-edited therapy for patients with specific forms of T-cell leukemia and lymphoma.
September 23, 2026
ArcaScience Has Launched Flow AI Drug Assessment SoftwareThe new system utilizes 24 specialized AI models to streamline regulatory-grade drug benefit-risk assessments.
September 23, 2026
ATM Inhibition Boosted Pig Genome EditingResearchers successfully increased targeted gene insertion rates in pig zygotes using ATM inhibition.
September 23, 2026
BioAro Launched LONgevity+ Bioactives InternationallyThe biotech firm has expanded its healthspan-focused product line into the United States and United Kingdom markets.
